Join us at eyeforpharma Barcelona March 14-16, 2017 in Barcelona, Spain where Kobi Gershoni, Co-Founder & Chief Research Officer of Signals Analytics, will discuss “Maximizing the Potential of Your Pipeline by Utilizing Signals Intelligence to Align with the Patient Decision Journey and Patient Desired Outcomes".
Visit the event's site for more details.
Maximizing the Potential of Your Pipeline by Utilizing Signals Intelligence to Align with the Patient Decision Journey and Patient Desired Outcomes
- Improve health outcomes by uncovering real, perceived and hidden barriers that define therapeutic value.
- Drive pipeline optimization by aligning your portfolio with patient behavior, HCP preferences, and choices of care - all critical to a successful launch.
- Optimize patient adherence by probing real-world attitudes and sentiment toward treatment regimes and patient engagement approaches.
Co-Founder & Chief Research Officer
Prior to co-founding Signals, Kobi was a Senior Analyst and Information Officer for an elite intelligence unit in the Israel Defense Forces, where he began to contemplate and refine the incorporation of open source intelligence into the growth plans of consumer brands and innovation agendas of life sciences companies. Kobi holds an MBA in Finance and Strategy as well as a BA in International Relations from Hebrew University in Jerusalem.